Cryoablation comparable to surgery for treating early-stage kidney cancer

A study published in the journal Radiology from John Hopkins University in Baltimore, America provides evidence that cryoablation is as effective as surgery for treating early-stage kidney cancer as evidenced from 10-year survival rates. Percutaneous cryoablation is a minimally invasive procedure that destroys cancer cells by freezing the tumour using a probe inserted through the […]

read more

Cryoablation is safe and effective for small kidney tumours

A new study published in the American Journal of Roentgenology confirms that image-guided percutaneous cryoablation is a safe and efficacious treatment for selected small renal cell carcinoma (RCC) tumours. Cryoablation is a non-invasive technique, which involves ‘freezing’ the tumour using fine needles inserted through the skin (percutaneous). This technique has not yet been widely adopted […]

read more

Percutaneous ablation for small renal masses

Current guidelines recommend partial nephrectomy as the preferred treatment option for small renal masses. Percutaneous ablation, such as radiofrequency ablation and cryoablation, are mainly considered for patients who are not suitable for surgery or who have other conditions (co-morbidities) that make them unfit for surgery. There is currently a lack of evidence comparing partial nephrectomy […]

read more

Outcomes following partial nephrectomy and percutaneous ablation for small renal masses

A study published in European Urology presents retrospective data from the Mayo Clinic in America regarding their experience with partial nephrectomy, percutaneous radiofrequency ablation (RFA) and percutaneous cryoablation for small renal masses (less than 4 cm, stage cT1). Long-term follow-up data from 1798 patients with primary cT1N0M0 renal tumours were treated with partial nephrectomy, RFA […]

read more

Percutaneous cryoablation for stage T1b tumours

A recent study published in Cardiovascular and Interventional Radiology this month looked at the use of percutaneous cryoablation for stage T1b (4.1-7.0 cm) renal cell carcinoma (RCC). This non-invasive technique, which involves ‘freezing’ the tumour using fine needles inserted through the skin (percutaneous), has not yet been widely adopted. The current study investigated the safety, […]

read more

Cryoablation versus partial nephrectomy for early stage renal masses

A recent study, published in the Journal of Cancer, conducted a systematic review and meta-analysis of the outcomes data for the use of cryoablation versus partial nephrectomy for early stage (T1) renal tumours. The review showed that cryoablation is linked with poorer oncologic outcomes than partial nephrectomy, but patients who underwent cryoablation had lower rates […]

read more

Outcomes after cryoablation versus nephrectomy

Percutaneous cryoablation (cryotherapy) is emerging as an alternative to partial nephrectomy (PN) for the removal of small, single kidney tumours while conserving kidney function (nephron-sparing). A new study provides support for cryotherapy, finding no significant differences in the risk for complications, kidney function, and cancer control outcomes compared with partial nephrectomy. The investigators suggested that […]

read more
Showing all 7 results
  TOP